Al Jazeera examines Cubas national healthcare system.

Related StoriesDespite decreased HIV/Helps deaths, disease still persists in South AfricaNew computer model predicts degrees of HIV care engagementNew study finds high prevalence of HIV among pregnant refugee women in OntarioIn another article, Inter Press Services examines HIV/Helps in Cuba, composing that the country includes a prevalence price of 0.18 % in the 15-49 age group, referred to as ‘exceptionally low’ by the Joint US Programme on HIV/AIDS. IPS looks at the task of the Cuban AIDS Avoidance Group , a national network of voluntary wellness advocates [who possess] been working for days gone by two decades to promote safe methods for curbing the spread of HIV and helping improve the quality of life for HIV-positive people, backing up the ongoing function of government health organizations, according to the news services .In the nivolumab group, the median overall survival was not reached in either PD-L1 subgroup. In the dacarbazine group, the median overall survival was slightly longer in the subgroup with positive PD-L1 position than in the subgroup with detrimental or indeterminate PD-L1 status . In both PD-L1 subgroups, nivolumab-treated patients had improved rates of objective response, as compared with dacarbazine-treated patients. In the subgroup with positive PD-L1 status, the target response rate was 52.7 percent in the nivolumab group versus 10.8 percent in the dacarbazine group. In the subgroup with unfavorable or indeterminate PD-L1 position, the objective response rate was 33.1 percent in the nivolumab group versus 15.7 percent in the dacarbazine group.